Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study)
PHASE2
The purpose of this study is to see whether combination treatment of Teclis...
A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma
PHASE1
This is a multicenter, multi-country, open-label, Phase 1b/2a dose-escalati...
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible
PHASE1
This is a phase 1/2, open label, study designed to assess the safety and cl...
Status
Unknown
Location
Department of Clinical Therapeutics, School of Medicine, National Kapodistrian University of Athens (NKUA)